Published Currently, many organizations are attempting to address their diverse intellectual property (IP) needs by implementing a series of distinct, AI-enhanced point solutions. Although these single-function tools offer an initial perception of cost savings, this...
Published In our July 2025 analysis, “The Semaglutide Story: Highlighting the Need to Maintain Patent Protection in Canada,” we examined the vulnerabilities exposed by the lapse of Novo Nordisk’s core compound patent (CA 2,601,784) for semaglutide—the active...
Published Just like websites, smartphones, and open-source software dramatically changed our modern era, artificial intelligence (AI) is an irreversible trend that will transform every aspect of society – from industries and the workforce to daily life and the...
Published The pace of change in intellectual property (IP) management is accelerating, and artificial intelligence (AI) is at the center of this transformation. For corporate IP professionals, AI is not just a tool for efficiency; it’s a strategic enabler that is...
Published “A brand dispute can cost tens of thousands – while protection costs only a few hundred.” A single brand dispute can cost tens of thousands. A trademark registration often costs only a few hundred. The difference between these outcomes lies not in legal...
Published Semaglutide, the blockbuster GLP-1 receptor agonist marketed under names like Ozempic® (type 2 diabetes) and Wegovy® (weight loss), has rapidly become one of the most consequential drugs in modern healthcare. As countries grapple with rising obesity and...
Would you like to receive our popular weekly news alerts straight to your inbox? Solely patent focused and only sent once a week means you can guarantee there will be something you are interested in reading instead of clogging up your inbox with junk. Sign up now!
